title: Intensive glucose lowering in cardiovascular risk management - unsolved questions - .
authors.forename: Michio
authors.initials: M
authors.lastname: Shimabukuro
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Masuzaki
authors.forename: Masataka
authors.initials: M
authors.lastname: Sata
mesh_terms: D003324:Coronary Artery Disease / Q000517:prevention & control*; D003510:Cyclohexanes / Q000494:pharmacology*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D038321:Glycemic Index / Q000187:drug effects*; D006801:Humans; D007294:Inositol / Q000031:analogs & derivatives* / Q000494:pharmacology; D008297:Male; D000077715:Nateglinide; D010649:Phenylalanine / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D003510:Cyclohexanes; D000077715:Nateglinide; D010649:Phenylalanine; D007294:Inositol; C102817:voglibose